BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Wex Pharmaceuticals Inc. Reports Year End Financial Results

  June 30, 2008

   · 

  1 min read
• Mesoblast Limited Equity Report By OzEquities

  June 30, 2008

   · 

  1 min read
• Genetown

  RXi Pharmaceuticals Included in Russell Microcap Index

  June 30, 2008

   · 

  1 min read
• Agendia BV’s MammaPrint(R) Receives Prestigious Award From Dutch Innovation

  June 30, 2008

   · 

  3 min read
• Lone Star Bio

  Rules-Based Medicine, Inc. Commercializes New Toxicity Biomarker Panel in Conjunction with FDA, European Medicines Evaluation Agency, C-Path and PSTC

  June 30, 2008

   · 

  1 min read
• Lone Star Bio

  Oncolin Therapeutics, Inc. Announces the Discovery of a New More Effective Anti-Cancer Treatment in Experimental Brain Tumor Models

  June 30, 2008

   · 

  1 min read
• Business

  Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer

  June 30, 2008

   · 

  1 min read
• Genetown

  Clinical Data, Inc. Included in Russell 3000® Index

  June 30, 2008

   · 

  1 min read
• Pharm Country

  Wyeth Declares Common and Preferred Stock Dividends

  June 30, 2008

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility and Testicular Function

  June 30, 2008

   · 

  1 min read